Carrier- and hapten-antibody producing cells, in vitro. IV. Effects of puromycin.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects*; D002352:Carrier Proteins; D002478:Cells, Cultured; D004912:Erythrocytes / Q000276:immunology; D006241:Haptens; D006736:Horses / Q000276:immunology; D007700:Kinetics; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009596:Nitrophenols / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology*; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013997:Time Factors
D002352:Carrier Proteins; D006241:Haptens; D009596:Nitrophenols; D011691:Puromycin; D015122:Mercaptopurine